Concentra Group Holdings Parent, Inc.
CON- Exchange
- NYSE
- Industry
- Services-Specialty Outpatient Facilities, NEC
- SEC CIK
- 0002014596
No open-market purchases or sales by Concentra Group Holdings Parent, Inc. insiders were filed in the last 90 days; 292 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Concentra Group Holdings Parent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Concentra Group Holdings Parent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ortenzio Robert A | Director | 181,286Indirect | Nov 10, 2026 | 8 |
| Anderson John Robert Jr. | See Remarks | 100,380 | Nov 6, 2026 | 2 |
| Conser Jonathan P. | See Remarks | 155,482 | Nov 6, 2026 | 3 |
| deLorimier John A. | See Remarks | 147,559 | Nov 6, 2026 | 3 |
| Devasia Thomas A. | See Remarks | 143,514 | Nov 6, 2026 | 3 |
| DiCanio Matthew T. | See Remarks | 471,770 | Nov 6, 2026 | 3 |
| Gallara Giovanni | See Remarks | 153,502 | Nov 6, 2026 | 3 |
| Gilbert Greg M. | See Remarks | 148,834 | Nov 6, 2026 | 3 |
| Kendall Danielle | See Remarks | 101,440 | Nov 6, 2026 | 3 |
| Kosuth Michael A. | See Remarks | 153,656 | Nov 6, 2026 | 3 |
| McAndrew Douglas R. | See Remarks | 155,482 | Nov 6, 2026 | 3 |
| Nelson Su Zan | See Remarks | 102,291 | Nov 6, 2026 | 2 |
| Newton William Keith | Director | 488,294 | Nov 6, 2026 | 3 |
| Rhine Michael D. | See Remarks | 112,176 | Nov 6, 2026 | 3 |
| Ryan Timothy F. | See Remarks | 148,834 | Nov 6, 2026 | 3 |
| Newton Raymond Tanner | EVP & Chief Financial Officer | 114,098 | Nov 6, 2026 | 2 |
| Bonner Brigid A. | Director | 19,485 | Nov 5, 2026 | 1 |
| Pegus Cheryl | Director | 24,729 | Nov 5, 2026 | 1 |
| Thomas Daniel | Director | 77,989 | Nov 5, 2026 | 1 |
| Watkins Marc R. | Director | 24,729 | Nov 5, 2026 | 1 |
| Gopal Vipin | Director | 19,485 | Nov 5, 2026 | 1 |
| Select Medical Corp | 10% Owner | 0 | Nov 25, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:31 PM ET | Aug 3 | 2 days | Ortenzio Robert ADirector | SSale | −130.0K | $31.84 | −$4.14M | −20.5%503.5K after | 10b5-1 |
| Jul 6, 2026 (view filing)4:05 PM ET | Jul 1 | 5 days | Ortenzio Robert ADirector | SSale | −130.0K | $30.50 | −$3.96M | −17.0%633.5K after | 10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Ortenzio Robert ADirector | SSale | −130.0K | $25.00 | −$3.25M | −14.6%763.5K after | 10b5-1 |
| May 11, 2026 (view filing) | May 8 | 3 days | Ortenzio Robert ADirector | SSale | −130.0K | $25.00 | −$3.25M | −12.7%893.5K after | 10b5-1 |